Join
Live feed
·
INSIDERFilingvia Quantisnow
Apimeds Pharmaceuticals US Inc. logo

Chairman and CMO Kim Christopher was granted 250,000 shares, increasing direct ownership by 909% to 277,500 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
APUS· Apimeds Pharmaceuticals US Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track APUS (Apimeds Pharmaceuticals US Inc.) and more on Quantisnow.